Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Care | 11 | 2023 | 650 | 3.690 |
Why?
|
| Ultrasonography | 18 | 2023 | 950 | 3.510 |
Why?
|
| Point-of-Care Systems | 7 | 2023 | 171 | 3.010 |
Why?
|
| Laryngoscopy | 3 | 2022 | 150 | 1.430 |
Why?
|
| Intensive Care Units, Pediatric | 4 | 2018 | 477 | 1.310 |
Why?
|
| Echocardiography | 6 | 2023 | 1055 | 1.310 |
Why?
|
| Intracranial Hypertension | 2 | 2021 | 121 | 1.300 |
Why?
|
| Critical Illness | 4 | 2023 | 598 | 1.150 |
Why?
|
| Catheterization, Central Venous | 2 | 2020 | 133 | 1.100 |
Why?
|
| Heart Arrest | 2 | 2023 | 350 | 1.020 |
Why?
|
| Vocal Cords | 2 | 2021 | 65 | 0.920 |
Why?
|
| Ultrasonography, Interventional | 4 | 2021 | 196 | 0.840 |
Why?
|
| Optic Nerve | 2 | 2021 | 117 | 0.810 |
Why?
|
| Pneumothorax | 1 | 2020 | 80 | 0.660 |
Why?
|
| Sepsis | 2 | 2021 | 478 | 0.620 |
Why?
|
| Child | 18 | 2023 | 24478 | 0.550 |
Why?
|
| Anesthesiology | 1 | 2018 | 94 | 0.520 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 17 | 0.510 |
Why?
|
| Venae Cavae | 1 | 2015 | 11 | 0.510 |
Why?
|
| Trachea | 1 | 2016 | 202 | 0.470 |
Why?
|
| Heart Diseases | 1 | 2019 | 484 | 0.460 |
Why?
|
| Heart Atria | 1 | 2015 | 317 | 0.420 |
Why?
|
| Intubation, Intratracheal | 1 | 2016 | 292 | 0.420 |
Why?
|
| Humans | 28 | 2024 | 124270 | 0.420 |
Why?
|
| Program Evaluation | 1 | 2015 | 448 | 0.410 |
Why?
|
| Sensitivity and Specificity | 3 | 2022 | 2040 | 0.400 |
Why?
|
| Point-of-Care Testing | 2 | 2023 | 27 | 0.390 |
Why?
|
| Oxazolidinones | 1 | 2011 | 33 | 0.370 |
Why?
|
| Acidosis, Lactic | 1 | 2011 | 30 | 0.370 |
Why?
|
| Acetamides | 1 | 2011 | 47 | 0.370 |
Why?
|
| Lactic Acid | 1 | 2011 | 147 | 0.360 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 783 | 0.340 |
Why?
|
| Pediatrics | 2 | 2016 | 1158 | 0.310 |
Why?
|
| Catheterization, Peripheral | 2 | 2021 | 127 | 0.280 |
Why?
|
| Infant, Newborn | 6 | 2024 | 8180 | 0.240 |
Why?
|
| Nicardipine | 1 | 2024 | 18 | 0.230 |
Why?
|
| Nitroprusside | 1 | 2024 | 46 | 0.230 |
Why?
|
| Fatal Outcome | 2 | 2017 | 356 | 0.220 |
Why?
|
| Competency-Based Education | 1 | 2023 | 69 | 0.200 |
Why?
|
| Infant | 7 | 2024 | 12463 | 0.190 |
Why?
|
| ROC Curve | 1 | 2022 | 561 | 0.180 |
Why?
|
| Larynx | 1 | 2021 | 70 | 0.180 |
Why?
|
| Ribs | 1 | 2020 | 45 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 2414 | 0.170 |
Why?
|
| Intracranial Pressure | 1 | 2020 | 182 | 0.160 |
Why?
|
| Positive-Pressure Respiration | 1 | 2019 | 82 | 0.160 |
Why?
|
| Anesthesia, General | 1 | 2019 | 117 | 0.150 |
Why?
|
| Heart | 1 | 2023 | 724 | 0.150 |
Why?
|
| Certification | 1 | 2018 | 67 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 1088 | 0.130 |
Why?
|
| Child, Preschool | 4 | 2019 | 14052 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2017 | 440 | 0.120 |
Why?
|
| Adult | 3 | 2023 | 29357 | 0.100 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 511 | 0.100 |
Why?
|
| Linezolid | 1 | 2011 | 25 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 480 | 0.090 |
Why?
|
| Lung | 1 | 2019 | 1485 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 628 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 2885 | 0.070 |
Why?
|
| Male | 5 | 2017 | 60887 | 0.070 |
Why?
|
| Mitochondria | 1 | 2011 | 691 | 0.070 |
Why?
|
| Female | 5 | 2017 | 66294 | 0.070 |
Why?
|
| Vasodilator Agents | 1 | 2024 | 204 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2021 | 86 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2024 | 397 | 0.050 |
Why?
|
| Adolescent | 3 | 2016 | 19308 | 0.050 |
Why?
|
| Catheters | 1 | 2021 | 89 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2024 | 1329 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6087 | 0.040 |
Why?
|
| Boston | 1 | 2016 | 110 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1096 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2870 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2016 | 236 | 0.030 |
Why?
|
| Observer Variation | 1 | 2016 | 302 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 16214 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2016 | 991 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 6252 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 8954 | 0.010 |
Why?
|